A turbulent year at the agency
- 1 February 2006
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (2) , 145-151
- https://doi.org/10.1038/nbt0206-145
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pessimistic response to FDA leadership changeNature Biotechnology, 2005
- Sandoz sues FDA over delay in first biogeneric approvalNature Biotechnology, 2005
- Overhauling oversight—European drug legislationNature Biotechnology, 2005
- Tysabri raises alarm bells on drug classNature Biotechnology, 2005